By Cheryl Selleny, Marketing and Communications
The International Society for CNS Clinical Trials and Methodology (ISCTM) 2013 Autumn Conference kicks off today at the Hyatt Penn’s Landing in Philadelphia. Bracket is excited to have many of our subject matter experts presenting posters, participating in panel discussions and co-chairing workshops and sessions. Below are the details of Bracket’s participation in the conference.
Day 1: September 30, 2013
Concurrent Workshops: 7:00pm to 9:00pm
Initiating Innovation in CNS Clinical Trials
Gary Sachs, MD
Stephen Marder, MD; David Daniel, MD
Suicidal Ideation and Behavior
Adam Butler; Phillip Chappell, MD
Day 2: October 1, 2013
Session: A Return to Rational CNS Drug Development: De-Risking Phase 3 Investments Through Rigorous Early Phase Drug Evaluations
Part 2: Designing the Right Series of Experiments
Co-Chairs: Gary Sachs, MD; Atul Mahableshwarkar, MD
Poster Session/Reception: 6:00pm to 8:00pm
Identification of PANSS Items of Particular Challenge to Raters in Adolescent Schizophrenia Clinical Trials
Joan Busner; David Daniel; Robert Findling
Do Rater Certification Procedures Identify Poor Raters?
David Daniel; Alan Kott
Impact of overzealous patients and raters on drug-placebo separation in an MDD Trial: Analysis of Tandem Ratings
Dan DeBonis; Rachel Cummings; Gary Sachs
Electronic administration of a clinical trials version of the MMSE (eMMSE-CT)
Priscilla Sameulson; Dan DeBonis; David S. Miller
What are optimal cognitive outcomes for trials in preclinical Alzheimer’s Disease?
Keith A. Wesnes
For the full agenda, follow this link .